Digestive system fistula originates most frequently as a complication after surgical procedures, less often occurs in the course of inflammatory diseases, but it can also result from neoplasm and injuries. the aim of the study was to analyze the causes and retrospectively assess the perioperative procedures as well as the results of digestive system fistula treatment. material and methods. own experience in digestive system fistula treatment was presented. The subject group consisted of 32 patients treated at the General Surgery, oncology and Endocrinology Clinical Department between 01.05.2005 and 30.04.2010 due to different digestive tract diseases. The causes of the occurrence of digestive system fistula, methods and results of treatment were analyzed. Results. The analysis covered 32 patients with digestive system fistula, among them 15 men and 17 women. Average age for men was 57 years (20-78), and for women 61 years (24-88). In 11 patients idiopathic fistula causally connected with primary inflammatory disease (7 cases) and with neoplasm (4 cases) was diagnosed, in 19 patients fistula was the result of complications after surgery, in 2 -after abdominal cavity injury. Recovery from fistula was achieved in 23 patients (72%) with the use of individually planned conservative therapy (TPN, EN, antibiotics, drainage, and others) and surgery, depending on the needs of individual patient. 5 patients (16%) died, whereas in 4 left (12%) recovery wasn't achieved (fistula in palliative patients, with advanced stages of neoplasm -bronchoesophageal fistula, the recurrence of uterine carcinoma). conclusions. Recently the results of digestive system fistula treatment showed an improvement which manifests itself in mortality decrease and shortening of fistula healing time. Yet, digestive system fistula as a serious complication still poses a very difficult surgical problem.
Intestinal fistula still constitute a crux chirurgorum. Postoperative fistula which are to some extent causally connected with surgical manual procedure create the biggest challenge to surgeons. The most frequently occurring form of postoperative fistula is anastomosis leakage resulting, as it has been considered for a long time, from: ischemia of anastomosed segments of digestive system (esophagus, stomach, intestine), excessive tension in anastomosed tissues, infections, a mechanical obstacle below anastomosis or also bad biological quality of tissues -in case of severe and prolonged inflammatory conditions, and also radiation-induced inflammation (injury) of intestines. Fistula originated in the course of nonspecific intestinal inflammatory diseases (Leśniowski-Crohn's Disease -Ch L-C, ulcerative large intestine inflammation -colitis ulcerosa), severe form of acute pancreatitis or 33 Digestive system fistula -a problem still relevant today intestinal diverticulosis pose another problem. Moreover, fistula can occur in the course of advanced forms of neoplasm, after bodily injuries resulting from communications and industrial accidents as well as gunshots.
The basic aim of a medical care of a patient with fistula is the assessment of general and local condition, proper diagnostic procedures (explaining the etiology and determining the topography of fistula) as well as the assessment of chances of healing fistula with the use of conservative therapy. In a patient who is stable in terms of hemodynamic condition, without symptoms of focal infection (abscess), without symptoms of diffuse peritonitis, with preserved patency of digestive tract above and below fistula and effective drainage of fistula contents conservative therapy should be considered. Whereas in patients with terminal fistula of the whole cross-section of the lumen of digestive tract, with no chances of healing by means of conservative therapy, surgical treatment should be considered -after proper preparation: compensation of aqua-electrolyte disturbances and achieving suitable nourishment state through parenteral and intraintestinal nutrition.
Digestive system fistula which were initially diagnosed as prognosticating healing through conservative therapy but secreting large amounts of fistula contents for a long time, without tendency to reduce the secretion, also require surgical treatment. It should be remembered that the results of fistula surgery are burdened with the risk of the occurrence of new fistula and a significant postoperative mortality. Hospital mortality in patients with digestive system fistula ranges in different series from 5 to 20%, and may even reach 40%. Fistula recurrence after their surgery also poses a serious problem and ranges in the area of 10-20%, and even over 30% (1) (2) (3) (4) (5) .
Introducing of parenteral and intraintestinal nutrition treatment decreased mortality which previously oscillated in the 40-85% range. Suitable conservative management allow the healing of over 80% of intestinal fistula. Around 20% of fistula require reconstructive surgery. Among fistula that prognosticate healing through conservative therapy are those with low secretion, with effective drainage and late disclosure of fistula after surgery (5-6 days). In case of early postoperative fistula the occurrence of symptoms of diffuse peritonitis, abscess, damp patch or major bleeding enforces surgical intervention. Whereas delayed surgical treatment is suggested when fistula secretion is not significantly lower after 4 weeks or decreases only slightly and the phenomenon of idiopathic closure of fistula does not occur. Postoperative fistula as well as fistula accompanying the course of neoplasm and inflammatory diseases or occurring after injuries pose a still topical problem for all teams of doctors and nurses working at general surgery and oncology departments. For this reason the authors decided to analyze difficulties connected with diagnosis and treatment of fistula on the basis of own clinical experience during last 5 years.
The aim of the study was to retrospectively analyze the causes, methods of treatment and results of digestive system fistula treatment as well as to determine the procedures which may lead to the improvement of the results and to recommend the preventive measures lowering the risk of surgery-induced fistula based on current expertise in the field.
MATERIAL AND METHoDS
Analysis covered the period from 01.05.2005 to 30.04.2010 (5 years). At that time 18 500 patients were treated and 8800 operated on at the General Surgery, oncology and Endocrinology Clinical Department.
The group of 32 patients with digestive system fistula, among them 15 men and 17 women, were subjected to the analysis. Within the 32 patients "idiopathic" fistula accompanying the course of neoplasm and inflammatory diseases, severe form of acute pancreatitis and non-specific inflammatory diseases of intestines and fistula, which resulted from surgical procedures performed due to neoplastic and non-neoplastic diseases, were analyzed.
Analysis covered the causes of the occurrence of digestive system fistula, their types, methods and results of their treatment, time of treatment and complications related to the treatment of already existing fistula.
During clinical studies the following general rules of therapeutic management in patients with fistula were adopted: 1) diagnosis of fistula (anastomosis leakage), determination of causes, type and loca-tion of fistula; 2) application of conservative therapy based on the effective active or passive drainage, depending on the local condition as well as proper compensation of aquaelectrolyte disturbances in a patient; 3) sitotherapy through parenteral, intraintestinal or combined nutrition; 4) antibiotic-therapy depending on the assessment of clinical condition, microbiological examination and antibiogram; 5) continual assessment of general and local clinical condition, competence of organs during treatment; 6) surgical treatment, depending on clinical condition, in case of lack of progress during conservative therapy. Planned intervention no earlier than after 4 weeks of treatment. In case of diffuse peritonitis, septic state, obstruction and bleeding which can not be subjected to conservative therapy the necessity of urgent surgical intervention appears; 7) specific proceeding in selected clinical situations, including the use of somatostatin in the treatment of upper segment of gastrointestinal tract fistula and pancreatic fistula.
The aim of the analysis was also to determine the procedures which might lower the risk of the occurrence of surgery-induced fistula and improve the results of fistula treatment.
The final points of the analysis were: 1) cure of fistula, Abbreviations: ŻP -parenteral nutrition, A -antibiotics, pm -anti-mycosis drugs, An -analgesic drugs, IPP -proton pump inhibitors, PK -prokinetics, hdcz -micro-molecular heparin, IAKP -platelet aggregation inhibitor, ASA -acetylsalicylic acid derivatives, S -steroids, Som -somatostatin, Ap -pressor amines, Ins -insulin, pkrw -antihemorrhagic drugs, m -diuretics, N -nootropic drugs, KKcz -erythrocytes concentrate, ffP -freshly frozen plasma, chKL -classic cholecystectomy, chLAP -laparoscopic cholecystectomy, ERcP -endoscopic retrograde cholangiopancreatography, PŻW -common bile duct, cth -chemotherapy, Rth -radiotherapy, tRth -teleradiotherapy, bRth -brachytherapy, ch. L-c -Leśniowski-Crohn's disease, Ozt -acute pancreatitis 2) lack of cure -but the result of treatment alleviating fistula symptoms, 3) death.
Types of fistula and their number, methods, time and results of their treatment together with demographic data were presented in tables.
RESULTS
over the period 05.2005 -04.2010 the total of 18 500 patients were treated and 8800 operated on at the General Surgery, oncology and Endocrinology Clinical Department.
Within that time 32 patients with digestive system fistula, among them 15 men and 17 women, were treated. Average age for men was 57 years (20-78), and for women 61 years .
Among 4 patients with "idiopathic" fistula in the course of advanced stages of neoplastic diseases (tab. 1) the satisfactory effect of alleviating fistula symptoms was achieved in 3 of them; one person died of primary disease (pulmonary carcinoma). In all patients therapeutic management consisted in compensation of aquaelectrolyte disturbances and sitotherapy.
Within the subgroup of 7 patients with "idiopathic" fistula resulting from inflammatory diseases 4 people were treated due to intestinal fistula in the course of Leśniowski-
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Digestive system fistula -a problem still relevant today Crohn's disease; 3 patients underwent surgery with good results; in one woman trace intestinal fistula in caesarean section scar healed after conservative therapy (tab. 2 and 3).
Surgery-induced fistula after surgical operations of digestive system neoplasm -carcinoma of the pancreas, colonic carcinoma, carcinoma of the stomach constitute a significant clinical problem in surgery. Fistula of pancreatoenterostomy after proximal resection of the pancreas is very difficult to cure. After Digestive system fistula -a problem still relevant today the treatment covered 7 patients with small intestine fistula, 3 patients with duodenal fistula, 1 patient with biliary fistula after cholecystectomy and 2 patients with fistula in anastomosis of small intestine and transverse colon. In this subgroup one patient died (condition after cerebral stroke, fixed auricular fibrillation), in whom extensive resection of small intestine, which showed necrotic change resulting from upper mesenteric embolism, was performed and subsequently right-sided hemicolectomy with resection of the remaining part of small intestine was also performed -in connection with the dilation of necrosis, emergence of intestinal fistula in its area and symptoms of diffuse peritonitis. In the rest of patients results of fistula treatment were satisfactory. Summing up the analysis of 32 patients with digestive system fistula the following was revealed: in 11 patients idiopathic fistula caus- 
DISCUSSIoN
Digestive system fistula may occur "spontaneously" in the course of neoplasm or inflammatory diseases, may result from an injury or they may also occur as iatrogenic fistula, emerging as a result of surgical procedure or radiotherapy. An increased risk of complications in the form of postoperative digestive system fistula should be considered in elderly patients, with medical history of metabolic and neoplastic diseases, after past irradiation, after previous laparotomy, with renal failure (4) .
Iatrogenic injury of intestines during the operation is one of the most frequent causes of the occurrence of fistula, which may appear in different time period after surgery. Primary procedure is often performed as an urgent intervention, without the possibility of metabolic preparation of a patient. In medical writing (3-10, 16, 17) it is emphasized that fistula occur more often in patients operated on due to urgent indications. The risk of the occurrence of surgery-induced fistula rises along with a patient's age; in the presented group of patients the average age was 59 years. In patients having medical history of diabetes, other metabolic diseases, atheromatosis, obesity, neoplastic disease and malnutrition the risk of the occurrence of surgery-induced intestinal fistula is higher than in patients without such history. The necessity of carrying out extensive resections of intestines is also an unfavorable factor: it deepens catabolism, increases the risk of anastomosis leakage and has an adverse effect on the whole postoperative course (11-19).
Intestinal fistula originated in the course of Leśniowski-Crohn's disease raise a particularly difficult issue. In own experience patients with fistula in the course of this disease created in general a complex diagnostic and therapeutic problem. Fistula in the course of Leśniowski-Crohn's disease happen to be "multiorgan" -enterocutaneous, entero-intestinal, enterovesical -and may relate to both small and large intestine. Such a complex enterocutaneous and enterovesical fistula was diagnosed in 29-year-old female patient and was surgically treated at our clinical department with good result. Both conservative therapy (preparing a patient to a reconstructive procedure) as well as surgical treatment of fistula originated in the course of Leśniowski-Crohn's disease require high level knowledge of pathology and the ability to solve most difficult problems relating to surgical complications on doctors' side.
Yong Sik Yoon et al. (20) presented 254 patients with Ch. L-C from the years 1991-2008. out of this group in 83 patients 93 surgical procedures were carried out due to 122 intra-abdominal fistula. Entero-intestinal fistula were most frequent (30,3%); others occurred with the following frequency: enterocutaneous -23%, ileo-sigmoid -19,7%, ileocolic -9,7% and enterovesical fistula -9,7%. The frequency of the occurrence of individual types of fistula was comparable with data from other research centers. Patients with fistula more often suffered from sepsis related to the disease than patients without fistula, which from the biological analysis point of view seems to be fully justified.
Surgical treatment of digestive system fistula still causes many controversies, on account of the significance of the problem and high percentage of failure. Brenner et al. (21) analyzed a group of 135 patients with enterocutaneous fistula undergoing reconstructive procedures. In this group of patients the mortality of 8% and the recurrence of 7% were reported. The authors (22) on the bases of multifactor analysis discovered that the risk of mortality occurrence increases significantly the recurrence of fistula, and factors that increase the risk of recurrence are the following: non-specific intestinal inflammatory diseases, the break between the diagnosis and the surgical treatment longer than 36 weeks, localization of fistula inside small intestine as well as intestinal resection with the use of stapler suture. Depending on the technique of tissues anastomosis recurrences appeared in 35% cases after stapler resection, in 22% cases after simple suturing and in 11% cases after resection and hand suturing. Recurrences occurred in 12%, if the operation was performed prior to the 36 th week since diagnosis and in 36% if it was performed after this period. Apart from the right choice of preparation period, reduction of inflammatory infiltration in peritoneal cavity, alleviating the course of the technique leading to separation of infiltration from adhesions, achieving the proper nourishment preparative state and compensation of all aquaelectrolyte disturbances the resection procedure of intestine segment with anastomosis performed by the use of hand suturing is 4-times safer than stapler technique. own experience in reconstructive operations also points at hand suture as more delicate, less traumatizing, less crumpling and crushing tissues with inflammatory change as well as securing better biomechanics, higher flexibility of anastomosis, less strictures, faster return to physioanatomical characteristics of intestine. own experience is proven by the results of research conducted by Brennera et al. (21) .
Non-specific intestinal inflammatory diseases, and Leśniowski-Crohn's disease in particular, are important causes of idiopathic fistula. Fistula complicate the course of Ch L-C in up to 40% patients (23-27). The tumor necrosis factor (TNF -tumor necrosis factor) plays vital role in non-specific intestinal inflammatory diseases' pathogenesis, and Ch L-C in particular. Hence, clinical trials showed the effectiveness of guided therapy with the use of infliximab, a chimerical antibody anti-TNF, in the treatment of acute cases of the disease and complications in the form of fistula. Therapy in cases of fistula treatment should last at least 8 weeks (27). Clinical experiments with adalimumab, human monoclonal antibody anti-TNF, proved the effectiveness in re-emission induction in patients with severe or moderate form of L-C disease. Moreover, it was observed that adalimumab is safe and effective in re-emission induction in patients with bad tolerance to infliximab (22). In randomized examinations of III phase, with double blind test, Colombel et al. (22) showed that in patients with active form of Ch L-C the adalimumab therapy in fistula healing induction is more effective than placebo. out of 31 patients with fistula the cure was achieved in 90% cases (28/31) over one year of observation. Therapy with weekly doses of 40 mg intravenously lasted from 26 to 56 weeks, depending on fistula status.
Another problem which seems to be more and more frequent -due to the elongation of lifespan, better results of oncologic treatment and sort of accumulation of side effects connected with applied therapy, including unfavorable effects of irradiation -are complications in the form of inflammatory conditions and fistula, even late after termination of treatment (24) . our experience show that the treatment of such fistula, i.e. rectovaginal fistula, sometimes combined with the recurrence of neoplastic disease, is very often ineffective. Therapy in such a state should be oriented toward the improvement of the comfort of functioning in these patients in terms of fighting the pain, self-care and personal hygiene.
Fistula resulted from severe form of acute pancreatitis, related to the infecting necrosis of the pancreas and retroperitoneal tissue as well as aggressive action of pancreatic juice on intra-peritoneal organs, are difficult to cure, however they constitute a slightly different problem than pancreato-intestinal fistula emerging after resection procedures carried out due to carcinoma of the pancreas or chronic inflammation of the pancreas (30, 31). Majority of fistula can be cured with the use of conservative methods, including effective drainage. The frequency of fistula following resection procedures of the pancreas ranges from few to several percent (29, 30, 31) . In most cases, thanks to the effective drainage and conservative therapy (guided antibiotic-therapy, parenteral and intraintestinal nutrition, somatostatin therapy) cure can be achieved. Additional difficulty may be bleeding from "post-resection area of the pancreas", which in rare cases may result in the death of a patient within the postoperative period as a result of impossible to control hemorrhage.
Gui and Wang (31) analyzed anastomosis leakage in the group of 653 patients, in whom low front resection of the rectum was performed. The findings were as follows: in the group of patients with preoperative RT 13,3% (25/195) cases of leakage, in the group without preoperative radiotherapy -4.5% (20/448) cases of leakage. As a result of multifactor analysis they came to the conclusion that the only factor leading to the high risk of leakage in those patients was the distance between the anastomosis and the edge of the rectum (less than 4 cm). At the same time the authors (31) determined that the factors mentioned below do not increase the risk of leakage after front resection of the rectum: sex, BMI, nicotinism, preoperative CT, concentration of albumins, hemoglobin, the size of tumor, intra-operative loss of blood, operation time, the degree of TNM progression as well as preventive stoma.
Within operative procedures drainage of the pelvis, optional preventive stoma, safe anastomosis at the level of at least 4 cm from the edge of anus were routinely taken into account.
The treatment of digestive system fistula included compensation of aqua-electrolyte disturbances, local infection and septic complications control, securing proper drainage (effective removal of the contents secreted from fistula), skin protection, guided antibiotictherapy and early application of the complete parenteral and intraintestinal nutrition.
Nutritional preparation of a patient to subsequent reconstructive operations is of basic significance. Equally important is parenteral or intraintestinal nutrition of a patient in the postoperative period (15, 16, 17). The aim of parenteral nutrition is to supply the adequate amount of calories, in the situation when the exclusion of gastrointestinal passage is necessary (15, 17, 18) .
Malnutrition prevention has a great significance for the right healing of fistula.
Almost all patients described in this paper received complete parenteral nutrition. Sitotherapy is burdened with the risk of specific complications. During the parenteral nutrition therapy complications related to the infection of catheter in the central vein may occur. In the analyzed group of patients it occurred in 2 cases. Metabolic complications constitute the other group of complications. Regular monitoring of metabolism and constant adjustment of nutritious mixture makeup to the needs of patients ensured safe sitotherapy.
CoNCLUSIoNS
Complex treatment of surgery-induced complications, namely intestinal fistula, allowed to achieve recovery in particularly difficult cases presented in this study. The therapeutic procedures which were used, individualized according to the needs of a particular patient, respond to the guidelines presented in the Polish recommendations concerning fistula treatment.
